HealthSpot CEO Steve Cashman stated, ‘HealthSpot can be proud to be dealing with Littmann brand products that are trusted by doctors around the globe.’ Related StoriesReducing medical center readmissions through Transitional Treatment: an interview with Rani KhetarpalRE. Bob Kody, 3M Littmann Global Business Director stated, ‘3M is excited about the opportunity to work with HealthSpot to introduce a convenient, innovative healthcare delivery model through its Care4 Stations. ACP’s High-Value, Cost-Conscious Care Initiative will assess benefits, harms, and costs of diagnostic testing and treatments for different diseases to determine if they provide value – – medical benefits that are commensurate with their costs and outweigh any harms.Maloney, M.D.: Abroad Screening for Tuberculosis in U.S.-Bound Refugees and Immigrants Tuberculosis is the second most common reason behind death from infectious illnesses in the global globe.1 Through the period from 1990 through 2003, the incidence of tuberculosis increased globally.2 The World Health Company has reported that Asia and sub-Saharan Africa accounted for 84.1 percent of the estimated 8.8 million new cases of tuberculosis worldwide in 2005.3 Global migration has affected the epidemiology of tuberculosis in developed countries greatly. In 2007, foreign-born people accounted for 57.8 percent of new cases of tuberculosis in the United States.4 For the reason that full year, the tuberculosis price in the usa was 20.6 instances and 2.1 cases per 100,000 population among foreign-born and U.S.-born persons, respectively.4 Furthermore, 27.5 percent of tuberculosis cases among foreign-born persons are diagnosed within 2 years following the person’s arrival in the United States.5 Approximately 400,000 immigrants and 50,000 to 70,000 refugees get to america annually, many from countries with a high incidence of tuberculosis.6 Therefore, these populations will probably contribute substantially to the tuberculosis burden among foreign-born persons in United States.